252 related articles for article (PubMed ID: 32526787)
1. Nonalcoholic Steatohepatitis Promoting Kinases.
Ibrahim SH; Hirsova P; Malhi H; Gores GJ
Semin Liver Dis; 2020 Nov; 40(4):346-357. PubMed ID: 32526787
[TBL] [Abstract][Full Text] [Related]
2. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.
Ibrahim SH; Hirsova P; Gores GJ
Gut; 2018 May; 67(5):963-972. PubMed ID: 29367207
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
Farrell GC; Haczeyni F; Chitturi S
Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204
[TBL] [Abstract][Full Text] [Related]
5. Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis.
Hirsova P; Ibrabim SH; Gores GJ; Malhi H
J Lipid Res; 2016 Oct; 57(10):1758-1770. PubMed ID: 27049024
[TBL] [Abstract][Full Text] [Related]
6. The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.
Lake AD; Novak P; Hardwick RN; Flores-Keown B; Zhao F; Klimecki WT; Cherrington NJ
Toxicol Sci; 2014 Jan; 137(1):26-35. PubMed ID: 24097666
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Lipotoxic Endoplasmic Reticulum (ER) Stress in Nonalcoholic Steatohepatitis (NASH).
Parthasarathy G; Malhi H
Methods Mol Biol; 2022; 2455():243-254. PubMed ID: 35212999
[TBL] [Abstract][Full Text] [Related]
8. Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner.
Kakazu E; Mauer AS; Yin M; Malhi H
J Lipid Res; 2016 Feb; 57(2):233-45. PubMed ID: 26621917
[TBL] [Abstract][Full Text] [Related]
9. Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice.
Lebeaupin C; Vallée D; Rousseau D; Patouraux S; Bonnafous S; Adam G; Luciano F; Luci C; Anty R; Iannelli A; Marchetti S; Kroemer G; Lacas-Gervais S; Tran A; Gual P; Bailly-Maitre B
Hepatology; 2018 Aug; 68(2):515-532. PubMed ID: 29457838
[TBL] [Abstract][Full Text] [Related]
10. The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease.
Song MJ; Malhi H
Pharmacol Ther; 2019 Nov; 203():107401. PubMed ID: 31419516
[TBL] [Abstract][Full Text] [Related]
11. Mixed Lineage Kinase 3 Mediates the Induction of CXCL10 by a STAT1-Dependent Mechanism During Hepatocyte Lipotoxicity.
Tomita K; Kabashima A; Freeman BL; Bronk SF; Hirsova P; Ibrahim SH
J Cell Biochem; 2017 Oct; 118(10):3249-3259. PubMed ID: 28262979
[TBL] [Abstract][Full Text] [Related]
12. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and non-alcoholic fatty liver diseases.
Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
[TBL] [Abstract][Full Text] [Related]
14. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C
Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645
[TBL] [Abstract][Full Text] [Related]
15. To die or not to die: death signaling in nonalcoholic fatty liver disease.
Akazawa Y; Nakao K
J Gastroenterol; 2018 Aug; 53(8):893-906. PubMed ID: 29574534
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol accumulation in hepatocytes mediates IRE1/p38 branch of endoplasmic reticulum stress to promote nonalcoholic steatohepatitis.
Sozen E; Demirel-Yalciner T; Sari D; Ozer NK
Free Radic Biol Med; 2022 Oct; 191():1-7. PubMed ID: 35995397
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells.
Magee N; Zou A; Zhang Y
Biomed Res Int; 2016; 2016():5170402. PubMed ID: 27822476
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.
Mota M; Banini BA; Cazanave SC; Sanyal AJ
Metabolism; 2016 Aug; 65(8):1049-61. PubMed ID: 26997538
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte TNF Receptor-Associated Factor 6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lysine 6-Linked Polyubiquitination of Apoptosis Signal-Regulating Kinase 1.
Wang Y; Wen H; Fu J; Cai L; Li PL; Zhao CL; Dong ZF; Ma JP; Wang X; Tian H; Zhang Y; Liu Y; Cai J; She ZG; Huang Z; Li W; Li H
Hepatology; 2020 Jan; 71(1):93-111. PubMed ID: 31222801
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
